Clinical Trial Update: Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing FlutiForm to Fluticasone Plus Formoterol in adults with severe asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchial Asthma

Drugs mentioned

• FlutiForm (fluticasone propionate/formoterol)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Asthma, Bronchial | Phase 3 | Status: COMPLETED